nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—type 2 diabetes mellitus	0.222	1	CbGaD
Aminosalicylic Acid—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0894	0.227	CbGbCtD
Aminosalicylic Acid—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0894	0.227	CbGbCtD
Aminosalicylic Acid—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0825	0.209	CbGbCtD
Aminosalicylic Acid—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0677	0.172	CbGbCtD
Aminosalicylic Acid—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0649	0.165	CbGbCtD
Aminosalicylic Acid—MPO—artery—type 2 diabetes mellitus	0.00305	0.0864	CbGeAlD
Aminosalicylic Acid—MPO—endothelium—type 2 diabetes mellitus	0.00258	0.073	CbGeAlD
Aminosalicylic Acid—PTGS2—leg—type 2 diabetes mellitus	0.00253	0.0716	CbGeAlD
Aminosalicylic Acid—PTGS2—hindlimb—type 2 diabetes mellitus	0.00226	0.0639	CbGeAlD
Aminosalicylic Acid—CHUK—cardiovascular system—type 2 diabetes mellitus	0.00223	0.063	CbGeAlD
Aminosalicylic Acid—CHUK—adipose tissue—type 2 diabetes mellitus	0.00196	0.0556	CbGeAlD
Aminosalicylic Acid—ALOX5—islet of Langerhans—type 2 diabetes mellitus	0.00173	0.0491	CbGeAlD
Aminosalicylic Acid—PTGS1—artery—type 2 diabetes mellitus	0.00145	0.041	CbGeAlD
Aminosalicylic Acid—PTGS2—artery—type 2 diabetes mellitus	0.00138	0.0392	CbGeAlD
Aminosalicylic Acid—CHUK—liver—type 2 diabetes mellitus	0.00138	0.039	CbGeAlD
Aminosalicylic Acid—ALOX5—cardiovascular system—type 2 diabetes mellitus	0.00125	0.0355	CbGeAlD
Aminosalicylic Acid—PTGS1—endothelium—type 2 diabetes mellitus	0.00122	0.0346	CbGeAlD
Aminosalicylic Acid—ALOX5—pancreas—type 2 diabetes mellitus	0.00122	0.0345	CbGeAlD
Aminosalicylic Acid—PTGS2—endothelium—type 2 diabetes mellitus	0.00117	0.0331	CbGeAlD
Aminosalicylic Acid—ALOX5—adipose tissue—type 2 diabetes mellitus	0.00111	0.0313	CbGeAlD
Aminosalicylic Acid—MPO—cardiovascular system—type 2 diabetes mellitus	0.00106	0.03	CbGeAlD
Aminosalicylic Acid—MPO—kidney—type 2 diabetes mellitus	0.00104	0.0294	CbGeAlD
Aminosalicylic Acid—MPO—pancreas—type 2 diabetes mellitus	0.00103	0.0292	CbGeAlD
Aminosalicylic Acid—Droxidopa—ADRB3—type 2 diabetes mellitus	0.000908	0.244	CrCbGaD
Aminosalicylic Acid—ALOX5—liver—type 2 diabetes mellitus	0.000776	0.0219	CbGeAlD
Aminosalicylic Acid—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000665	0.0188	CbGeAlD
Aminosalicylic Acid—Methyldopa—ADRA2A—type 2 diabetes mellitus	0.000658	0.177	CrCbGaD
Aminosalicylic Acid—MPO—liver—type 2 diabetes mellitus	0.000656	0.0186	CbGeAlD
Aminosalicylic Acid—Mesalazine—PPARG—type 2 diabetes mellitus	0.000581	0.156	CrCbGaD
Aminosalicylic Acid—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000503	0.0142	CbGeAlD
Aminosalicylic Acid—PTGS1—kidney—type 2 diabetes mellitus	0.000493	0.0139	CbGeAlD
Aminosalicylic Acid—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000481	0.0136	CbGeAlD
Aminosalicylic Acid—PTGS2—kidney—type 2 diabetes mellitus	0.000471	0.0133	CbGeAlD
Aminosalicylic Acid—PTGS2—pancreas—type 2 diabetes mellitus	0.000468	0.0132	CbGeAlD
Aminosalicylic Acid—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000444	0.0126	CbGeAlD
Aminosalicylic Acid—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000424	0.012	CbGeAlD
Aminosalicylic Acid—Droxidopa—ADRA2A—type 2 diabetes mellitus	0.000411	0.11	CrCbGaD
Aminosalicylic Acid—Malnutrition—Gliclazide—type 2 diabetes mellitus	0.000317	0.0016	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000316	0.00159	CcSEcCtD
Aminosalicylic Acid—Diflunisal—PTGS2—type 2 diabetes mellitus	0.000313	0.084	CrCbGaD
Aminosalicylic Acid—Flatulence—Gliclazide—type 2 diabetes mellitus	0.000313	0.00157	CcSEcCtD
Aminosalicylic Acid—Jaundice—Irbesartan—type 2 diabetes mellitus	0.000312	0.00157	CcSEcCtD
Aminosalicylic Acid—Nausea—Nateglinide—type 2 diabetes mellitus	0.000311	0.00156	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.00031	0.00156	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00031	0.00156	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000309	0.00156	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000306	0.00154	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000306	0.00154	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Metformin—type 2 diabetes mellitus	0.000305	0.00153	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000304	0.00153	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000303	0.00152	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000302	0.00152	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000301	0.00151	CcSEcCtD
Aminosalicylic Acid—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000301	0.00151	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000299	0.0015	CcSEcCtD
Aminosalicylic Acid—Urticaria—Glipizide—type 2 diabetes mellitus	0.000298	0.0015	CcSEcCtD
Aminosalicylic Acid—PTGS2—liver—type 2 diabetes mellitus	0.000298	0.00842	CbGeAlD
Aminosalicylic Acid—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000296	0.00149	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Losartan—type 2 diabetes mellitus	0.000296	0.00149	CcSEcCtD
Aminosalicylic Acid—Jaundice—Losartan—type 2 diabetes mellitus	0.000294	0.00148	CcSEcCtD
Aminosalicylic Acid—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000293	0.00147	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000293	0.00147	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Valsartan—type 2 diabetes mellitus	0.000291	0.00147	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000288	0.00145	CcSEcCtD
Aminosalicylic Acid—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000288	0.00145	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000288	0.00145	CcSEcCtD
Aminosalicylic Acid—Flatulence—Valsartan—type 2 diabetes mellitus	0.000287	0.00144	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000286	0.00144	CcSEcCtD
Aminosalicylic Acid—Rash—Repaglinide—type 2 diabetes mellitus	0.000286	0.00144	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000285	0.00144	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000285	0.00143	CcSEcCtD
Aminosalicylic Acid—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000285	0.00143	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000285	0.00143	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000284	0.00143	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000284	0.00143	CcSEcCtD
Aminosalicylic Acid—Flatulence—Orlistat—type 2 diabetes mellitus	0.000284	0.00143	CcSEcCtD
Aminosalicylic Acid—Headache—Repaglinide—type 2 diabetes mellitus	0.000284	0.00143	CcSEcCtD
Aminosalicylic Acid—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000283	0.00142	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000283	0.00142	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000282	0.00142	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000282	0.00142	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000282	0.00142	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000281	0.00142	CcSEcCtD
Aminosalicylic Acid—Diflunisal—ALB—type 2 diabetes mellitus	0.000279	0.0748	CrCbGaD
Aminosalicylic Acid—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000278	0.0014	CcSEcCtD
Aminosalicylic Acid—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000277	0.00139	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000276	0.00139	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000276	0.00139	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000276	0.00139	CcSEcCtD
Aminosalicylic Acid—Anorexia—Glyburide—type 2 diabetes mellitus	0.000275	0.00138	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000274	0.00138	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000272	0.00137	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Losartan—type 2 diabetes mellitus	0.000271	0.00136	CcSEcCtD
Aminosalicylic Acid—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00027	0.00136	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00027	0.00136	CcSEcCtD
Aminosalicylic Acid—Nausea—Repaglinide—type 2 diabetes mellitus	0.000269	0.00135	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000268	0.00135	CcSEcCtD
Aminosalicylic Acid—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000268	0.00135	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Metformin—type 2 diabetes mellitus	0.000265	0.00133	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000264	0.00133	CcSEcCtD
Aminosalicylic Acid—Flatulence—Metformin—type 2 diabetes mellitus	0.000262	0.00132	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Metformin—type 2 diabetes mellitus	0.00026	0.00131	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000258	0.0013	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000258	0.0013	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000257	0.00129	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000256	0.00129	CcSEcCtD
Aminosalicylic Acid—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000254	0.00128	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000254	0.00128	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000254	0.00127	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000253	0.00127	CcSEcCtD
Aminosalicylic Acid—Jaundice—Ramipril—type 2 diabetes mellitus	0.000252	0.00127	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000251	0.00126	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000251	0.00126	CcSEcCtD
Aminosalicylic Acid—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000251	0.00126	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.00025	0.00126	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000249	0.00125	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000249	0.00125	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000249	0.00125	CcSEcCtD
Aminosalicylic Acid—Dizziness—Glipizide—type 2 diabetes mellitus	0.000248	0.00125	CcSEcCtD
Aminosalicylic Acid—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000247	0.00124	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000246	0.00124	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000246	0.00123	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PTGS2—type 2 diabetes mellitus	0.000245	0.0659	CrCbGaD
Aminosalicylic Acid—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000245	0.00123	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000244	0.00122	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000241	0.00121	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000239	0.0012	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000238	0.0012	CcSEcCtD
Aminosalicylic Acid—Vomiting—Glipizide—type 2 diabetes mellitus	0.000238	0.0012	CcSEcCtD
Aminosalicylic Acid—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000237	0.00119	CcSEcCtD
Aminosalicylic Acid—Rash—Glipizide—type 2 diabetes mellitus	0.000236	0.00119	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000236	0.00119	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000236	0.00119	CcSEcCtD
Aminosalicylic Acid—Headache—Glipizide—type 2 diabetes mellitus	0.000235	0.00118	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000233	0.00117	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000233	0.00117	CcSEcCtD
Aminosalicylic Acid—Flatulence—Losartan—type 2 diabetes mellitus	0.000232	0.00117	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000232	0.00117	CcSEcCtD
Aminosalicylic Acid—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000232	0.00116	CcSEcCtD
Aminosalicylic Acid—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000231	0.00116	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000231	0.00116	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000231	0.00116	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000231	0.00116	CcSEcCtD
Aminosalicylic Acid—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00023	0.00116	CcSEcCtD
Aminosalicylic Acid—Urticaria—Glyburide—type 2 diabetes mellitus	0.000229	0.00115	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000228	0.00115	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000228	0.00115	CcSEcCtD
Aminosalicylic Acid—Anorexia—Valsartan—type 2 diabetes mellitus	0.000227	0.00114	CcSEcCtD
Aminosalicylic Acid—Headache—Pioglitazone—type 2 diabetes mellitus	0.000225	0.00113	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000224	0.00113	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000224	0.00113	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000224	0.00112	CcSEcCtD
Aminosalicylic Acid—Nausea—Glipizide—type 2 diabetes mellitus	0.000223	0.00112	CcSEcCtD
Aminosalicylic Acid—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000222	0.00112	CcSEcCtD
Aminosalicylic Acid—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000222	0.00111	CcSEcCtD
Aminosalicylic Acid—Rash—Glimepiride—type 2 diabetes mellitus	0.00022	0.00111	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00022	0.00111	CcSEcCtD
Aminosalicylic Acid—Rash—Sitagliptin—type 2 diabetes mellitus	0.00022	0.0011	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00022	0.0011	CcSEcCtD
Aminosalicylic Acid—Headache—Glimepiride—type 2 diabetes mellitus	0.000219	0.0011	CcSEcCtD
Aminosalicylic Acid—Headache—Sitagliptin—type 2 diabetes mellitus	0.000218	0.0011	CcSEcCtD
Aminosalicylic Acid—Anaemia—Losartan—type 2 diabetes mellitus	0.000218	0.0011	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000216	0.00109	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000212	0.00107	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000212	0.00107	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000212	0.00107	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000212	0.00106	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000212	0.00106	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Losartan—type 2 diabetes mellitus	0.000211	0.00106	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Metformin—type 2 diabetes mellitus	0.00021	0.00106	CcSEcCtD
Aminosalicylic Acid—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000209	0.00105	CcSEcCtD
Aminosalicylic Acid—Nausea—Glimepiride—type 2 diabetes mellitus	0.000208	0.00104	CcSEcCtD
Aminosalicylic Acid—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000207	0.00104	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000207	0.00104	CcSEcCtD
Aminosalicylic Acid—Anorexia—Metformin—type 2 diabetes mellitus	0.000206	0.00104	CcSEcCtD
Aminosalicylic Acid—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000206	0.00103	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000205	0.00103	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000205	0.00103	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000205	0.00103	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000204	0.00103	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000203	0.00102	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000202	0.00102	CcSEcCtD
Aminosalicylic Acid—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000201	0.00101	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.0002	0.00101	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.0002	0.00101	CcSEcCtD
Aminosalicylic Acid—Rash—Bromocriptine—type 2 diabetes mellitus	0.000199	0.001	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000199	0.000999	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000199	0.000998	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000198	0.000995	CcSEcCtD
Aminosalicylic Acid—Headache—Bromocriptine—type 2 diabetes mellitus	0.000198	0.000994	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000197	0.000992	CcSEcCtD
Aminosalicylic Acid—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000195	0.00098	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000195	0.000978	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000192	0.000966	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000191	0.000959	CcSEcCtD
Aminosalicylic Acid—Urticaria—Valsartan—type 2 diabetes mellitus	0.000189	0.00095	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000189	0.000949	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000188	0.000947	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000188	0.000947	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000188	0.000946	CcSEcCtD
Aminosalicylic Acid—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000187	0.000942	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000187	0.00094	CcSEcCtD
Aminosalicylic Acid—Urticaria—Orlistat—type 2 diabetes mellitus	0.000187	0.000939	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000186	0.000934	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000186	0.000934	CcSEcCtD
Aminosalicylic Acid—Anorexia—Losartan—type 2 diabetes mellitus	0.000183	0.000922	CcSEcCtD
Aminosalicylic Acid—Vomiting—Glyburide—type 2 diabetes mellitus	0.000183	0.000922	CcSEcCtD
Aminosalicylic Acid—Rash—Glyburide—type 2 diabetes mellitus	0.000182	0.000914	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000182	0.000913	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000181	0.00091	CcSEcCtD
Aminosalicylic Acid—Headache—Glyburide—type 2 diabetes mellitus	0.000181	0.000908	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000178	0.000894	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000177	0.000891	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000177	0.000891	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000176	0.000887	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000175	0.000881	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—PTGS2—type 2 diabetes mellitus	0.000174	0.0467	CrCbGaD
Aminosalicylic Acid—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000173	0.000871	CcSEcCtD
Aminosalicylic Acid—Urticaria—Metformin—type 2 diabetes mellitus	0.000172	0.000865	CcSEcCtD
Aminosalicylic Acid—Nausea—Glyburide—type 2 diabetes mellitus	0.000171	0.000861	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000171	0.000861	CcSEcCtD
Aminosalicylic Acid—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000171	0.000861	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000171	0.000859	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000167	0.000841	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000167	0.000841	CcSEcCtD
Aminosalicylic Acid—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000165	0.000828	CcSEcCtD
Aminosalicylic Acid—Rash—Gliclazide—type 2 diabetes mellitus	0.000163	0.000821	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000163	0.00082	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000163	0.000818	CcSEcCtD
Aminosalicylic Acid—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000162	0.000817	CcSEcCtD
Aminosalicylic Acid—Headache—Gliclazide—type 2 diabetes mellitus	0.000162	0.000816	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000162	0.000813	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000162	0.000813	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000162	0.000813	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000162	0.000812	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000161	0.000809	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00016	0.000806	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000157	0.000791	CcSEcCtD
Aminosalicylic Acid—Dizziness—Valsartan—type 2 diabetes mellitus	0.000157	0.000791	CcSEcCtD
Aminosalicylic Acid—Anorexia—Ramipril—type 2 diabetes mellitus	0.000157	0.000791	CcSEcCtD
Aminosalicylic Acid—Dizziness—Orlistat—type 2 diabetes mellitus	0.000155	0.000782	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—ALB—type 2 diabetes mellitus	0.000155	0.0416	CrCbGaD
Aminosalicylic Acid—Nausea—Gliclazide—type 2 diabetes mellitus	0.000154	0.000773	CcSEcCtD
Aminosalicylic Acid—Urticaria—Losartan—type 2 diabetes mellitus	0.000153	0.000768	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000152	0.000765	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000152	0.000765	CcSEcCtD
Aminosalicylic Acid—Vomiting—Valsartan—type 2 diabetes mellitus	0.000151	0.00076	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000151	0.000757	CcSEcCtD
Aminosalicylic Acid—Rash—Valsartan—type 2 diabetes mellitus	0.00015	0.000754	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00015	0.000753	CcSEcCtD
Aminosalicylic Acid—Vomiting—Orlistat—type 2 diabetes mellitus	0.000149	0.000751	CcSEcCtD
Aminosalicylic Acid—Headache—Valsartan—type 2 diabetes mellitus	0.000149	0.000749	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000148	0.000745	CcSEcCtD
Aminosalicylic Acid—Rash—Orlistat—type 2 diabetes mellitus	0.000148	0.000745	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000148	0.000745	CcSEcCtD
Aminosalicylic Acid—Headache—Orlistat—type 2 diabetes mellitus	0.000147	0.00074	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000143	0.000721	CcSEcCtD
Aminosalicylic Acid—Dizziness—Metformin—type 2 diabetes mellitus	0.000143	0.00072	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000142	0.000716	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000142	0.000713	CcSEcCtD
Aminosalicylic Acid—Nausea—Valsartan—type 2 diabetes mellitus	0.000141	0.00071	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00014	0.000703	CcSEcCtD
Aminosalicylic Acid—Nausea—Orlistat—type 2 diabetes mellitus	0.00014	0.000702	CcSEcCtD
Aminosalicylic Acid—Vomiting—Metformin—type 2 diabetes mellitus	0.000138	0.000693	CcSEcCtD
Aminosalicylic Acid—Rash—Metformin—type 2 diabetes mellitus	0.000137	0.000687	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Metformin—type 2 diabetes mellitus	0.000136	0.000686	CcSEcCtD
Aminosalicylic Acid—Headache—Metformin—type 2 diabetes mellitus	0.000136	0.000682	CcSEcCtD
Aminosalicylic Acid—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000135	0.00068	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000135	0.000678	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000132	0.000662	CcSEcCtD
Aminosalicylic Acid—Urticaria—Ramipril—type 2 diabetes mellitus	0.000131	0.000659	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00013	0.000656	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00013	0.000656	CcSEcCtD
Aminosalicylic Acid—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00013	0.000654	CcSEcCtD
Aminosalicylic Acid—Rash—Irbesartan—type 2 diabetes mellitus	0.000129	0.000648	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000129	0.000647	CcSEcCtD
Aminosalicylic Acid—Nausea—Metformin—type 2 diabetes mellitus	0.000129	0.000647	CcSEcCtD
Aminosalicylic Acid—Headache—Irbesartan—type 2 diabetes mellitus	0.000128	0.000644	CcSEcCtD
Aminosalicylic Acid—Dizziness—Losartan—type 2 diabetes mellitus	0.000127	0.00064	CcSEcCtD
Aminosalicylic Acid—Vomiting—Losartan—type 2 diabetes mellitus	0.000122	0.000615	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000122	0.000611	CcSEcCtD
Aminosalicylic Acid—Nausea—Irbesartan—type 2 diabetes mellitus	0.000121	0.000611	CcSEcCtD
Aminosalicylic Acid—Rash—Losartan—type 2 diabetes mellitus	0.000121	0.00061	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Losartan—type 2 diabetes mellitus	0.000121	0.000609	CcSEcCtD
Aminosalicylic Acid—Headache—Losartan—type 2 diabetes mellitus	0.000121	0.000606	CcSEcCtD
Aminosalicylic Acid—Nausea—Losartan—type 2 diabetes mellitus	0.000114	0.000575	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000113	0.000568	CcSEcCtD
Aminosalicylic Acid—Dizziness—Ramipril—type 2 diabetes mellitus	0.000109	0.000548	CcSEcCtD
Aminosalicylic Acid—Vomiting—Ramipril—type 2 diabetes mellitus	0.000105	0.000527	CcSEcCtD
Aminosalicylic Acid—Rash—Ramipril—type 2 diabetes mellitus	0.000104	0.000523	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000104	0.000522	CcSEcCtD
Aminosalicylic Acid—Headache—Ramipril—type 2 diabetes mellitus	0.000103	0.00052	CcSEcCtD
Aminosalicylic Acid—Nausea—Ramipril—type 2 diabetes mellitus	9.8e-05	0.000493	CcSEcCtD
Aminosalicylic Acid—PTGS2—Metabolism—KCNJ11—type 2 diabetes mellitus	1.42e-05	9.78e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—LPA—type 2 diabetes mellitus	1.42e-05	9.78e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GCKR—type 2 diabetes mellitus	1.42e-05	9.78e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HSD3B2—type 2 diabetes mellitus	1.42e-05	9.78e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IL6—type 2 diabetes mellitus	1.42e-05	9.75e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.42e-05	9.73e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC2A2—type 2 diabetes mellitus	1.42e-05	9.72e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PPP2CA—type 2 diabetes mellitus	1.41e-05	9.72e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.39e-05	9.57e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—LPL—type 2 diabetes mellitus	1.39e-05	9.56e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.39e-05	9.56e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.39e-05	9.53e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTR—type 2 diabetes mellitus	1.39e-05	9.52e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CETP—type 2 diabetes mellitus	1.38e-05	9.45e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.37e-05	9.41e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALDOB—type 2 diabetes mellitus	1.37e-05	9.38e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.36e-05	9.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ADCY5—type 2 diabetes mellitus	1.36e-05	9.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NAMPT—type 2 diabetes mellitus	1.36e-05	9.34e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.36e-05	9.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.36e-05	9.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—C3—type 2 diabetes mellitus	1.36e-05	9.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GCK—type 2 diabetes mellitus	1.35e-05	9.28e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IAPP—type 2 diabetes mellitus	1.34e-05	9.22e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.34e-05	9.21e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.33e-05	9.11e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC9A1—type 2 diabetes mellitus	1.32e-05	9.06e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ALB—type 2 diabetes mellitus	1.32e-05	9.05e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—AKT1—type 2 diabetes mellitus	1.31e-05	9e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PPP2CA—type 2 diabetes mellitus	1.31e-05	8.97e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.3e-05	8.93e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2L1—type 2 diabetes mellitus	1.3e-05	8.93e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CRP—type 2 diabetes mellitus	1.29e-05	8.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IRS2—type 2 diabetes mellitus	1.29e-05	8.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NFKB1—type 2 diabetes mellitus	1.29e-05	8.86e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.29e-05	8.82e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CCR5—type 2 diabetes mellitus	1.28e-05	8.81e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.28e-05	8.81e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SNAP25—type 2 diabetes mellitus	1.28e-05	8.78e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SREBF1—type 2 diabetes mellitus	1.28e-05	8.78e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PSMD6—type 2 diabetes mellitus	1.28e-05	8.78e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GLP1R—type 2 diabetes mellitus	1.27e-05	8.72e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CALM1—type 2 diabetes mellitus	1.27e-05	8.71e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.26e-05	8.68e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.26e-05	8.65e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—NOS3—type 2 diabetes mellitus	1.26e-05	8.65e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CTGF—type 2 diabetes mellitus	1.26e-05	8.62e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTHFR—type 2 diabetes mellitus	1.25e-05	8.61e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HMGCR—type 2 diabetes mellitus	1.24e-05	8.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GCG—type 2 diabetes mellitus	1.24e-05	8.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.24e-05	8.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NFKB1—type 2 diabetes mellitus	1.24e-05	8.51e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HMGA1—type 2 diabetes mellitus	1.24e-05	8.49e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.23e-05	8.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.22e-05	8.39e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.22e-05	8.37e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.22e-05	8.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PSMD6—type 2 diabetes mellitus	1.21e-05	8.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SNAP25—type 2 diabetes mellitus	1.21e-05	8.32e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—SRC—type 2 diabetes mellitus	1.2e-05	8.26e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HIF1A—type 2 diabetes mellitus	1.2e-05	8.21e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IRS2—type 2 diabetes mellitus	1.19e-05	8.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PRKCB—type 2 diabetes mellitus	1.19e-05	8.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ICAM1—type 2 diabetes mellitus	1.19e-05	8.15e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC2A2—type 2 diabetes mellitus	1.19e-05	8.14e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CYBA—type 2 diabetes mellitus	1.17e-05	8.06e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CALM1—type 2 diabetes mellitus	1.17e-05	8.04e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.17e-05	8.03e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOE—type 2 diabetes mellitus	1.17e-05	8.01e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CPT1A—type 2 diabetes mellitus	1.16e-05	7.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTR—type 2 diabetes mellitus	1.16e-05	7.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.16e-05	7.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.16e-05	7.94e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—SRC—type 2 diabetes mellitus	1.15e-05	7.93e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOA1—type 2 diabetes mellitus	1.15e-05	7.92e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—type 2 diabetes mellitus	1.15e-05	7.91e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NAMPT—type 2 diabetes mellitus	1.14e-05	7.82e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CALCA—type 2 diabetes mellitus	1.14e-05	7.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.13e-05	7.78e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—LIPC—type 2 diabetes mellitus	1.13e-05	7.77e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GCK—type 2 diabetes mellitus	1.13e-05	7.77e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HBA1—type 2 diabetes mellitus	1.13e-05	7.77e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.13e-05	7.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IRS1—type 2 diabetes mellitus	1.13e-05	7.74e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.12e-05	7.72e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.12e-05	7.71e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GCG—type 2 diabetes mellitus	1.11e-05	7.61e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.11e-05	7.61e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.1e-05	7.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC2A1—type 2 diabetes mellitus	1.1e-05	7.53e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CETP—type 2 diabetes mellitus	1.09e-05	7.5e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS2—type 2 diabetes mellitus	1.09e-05	7.47e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.08e-05	7.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS1—type 2 diabetes mellitus	1.08e-05	7.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.07e-05	7.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.07e-05	7.35e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TCF7L2—type 2 diabetes mellitus	1.07e-05	7.34e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CASP8—type 2 diabetes mellitus	1.06e-05	7.3e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AVP—type 2 diabetes mellitus	1.06e-05	7.25e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.06e-05	7.25e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EGFR—type 2 diabetes mellitus	1.05e-05	7.24e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.05e-05	7.22e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC2A4—type 2 diabetes mellitus	1.05e-05	7.22e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.05e-05	7.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT2—type 2 diabetes mellitus	1.04e-05	7.17e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IRS1—type 2 diabetes mellitus	1.04e-05	7.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOB—type 2 diabetes mellitus	1.02e-05	7.01e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.02e-05	6.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.02e-05	6.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SNAP25—type 2 diabetes mellitus	1.02e-05	6.97e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PSMD6—type 2 diabetes mellitus	1.02e-05	6.97e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SREBF1—type 2 diabetes mellitus	1.02e-05	6.97e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—EGFR—type 2 diabetes mellitus	1.01e-05	6.95e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EDN1—type 2 diabetes mellitus	1e-05	6.9e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—INS—type 2 diabetes mellitus	9.97e-06	6.85e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CTGF—type 2 diabetes mellitus	9.96e-06	6.84e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HMGCR—type 2 diabetes mellitus	9.88e-06	6.78e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LPL—type 2 diabetes mellitus	9.75e-06	6.7e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.74e-06	6.69e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ADRA2A—type 2 diabetes mellitus	9.66e-06	6.64e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT2—type 2 diabetes mellitus	9.64e-06	6.62e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GNB3—type 2 diabetes mellitus	9.56e-06	6.56e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.56e-06	6.56e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.54e-06	6.55e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—HMOX1—type 2 diabetes mellitus	9.51e-06	6.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PIK3R1—type 2 diabetes mellitus	9.47e-06	6.5e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	9.39e-06	6.45e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	9.28e-06	6.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	9.18e-06	6.3e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	9.18e-06	6.3e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SERPINE1—type 2 diabetes mellitus	9.16e-06	6.29e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.15e-06	6.28e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	9.14e-06	6.28e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BCL2—type 2 diabetes mellitus	9.12e-06	6.26e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	9.11e-06	6.26e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.98e-06	6.17e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	8.95e-06	6.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RELA—type 2 diabetes mellitus	8.91e-06	6.12e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	8.86e-06	6.09e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	8.86e-06	6.08e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	8.8e-06	6.04e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	8.8e-06	6.04e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—C3—type 2 diabetes mellitus	8.78e-06	6.03e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PIK3R1—type 2 diabetes mellitus	8.74e-06	6e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS3—type 2 diabetes mellitus	8.74e-06	6e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	8.7e-06	5.97e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOB—type 2 diabetes mellitus	8.64e-06	5.93e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	8.52e-06	5.85e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	8.49e-06	5.83e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.37e-06	5.75e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.35e-06	5.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AGT—type 2 diabetes mellitus	8.34e-06	5.73e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	8.27e-06	5.68e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—LPL—type 2 diabetes mellitus	8.25e-06	5.66e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.2e-06	5.63e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOE—type 2 diabetes mellitus	8.17e-06	5.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LEP—type 2 diabetes mellitus	8.17e-06	5.61e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	8.16e-06	5.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—type 2 diabetes mellitus	8.1e-06	5.56e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.08e-06	5.55e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	8.07e-06	5.54e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—type 2 diabetes mellitus	8e-06	5.49e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	7.83e-06	5.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	7.74e-06	5.31e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.71e-06	5.29e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	7.69e-06	5.28e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CCR5—type 2 diabetes mellitus	7.6e-06	5.22e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	7.59e-06	5.21e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.59e-06	5.21e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	7.55e-06	5.19e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NFKB1—type 2 diabetes mellitus	7.52e-06	5.16e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AKT1—type 2 diabetes mellitus	7.47e-06	5.13e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	7.45e-06	5.12e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	7.44e-06	5.11e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	7.43e-06	5.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	7.32e-06	5.03e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	7.29e-06	5.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.29e-06	5.01e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	7.23e-06	4.97e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	7.21e-06	4.95e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—AKT1—type 2 diabetes mellitus	7.18e-06	4.93e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	7.08e-06	4.86e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IRS2—type 2 diabetes mellitus	7.06e-06	4.85e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	7.04e-06	4.83e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SRC—type 2 diabetes mellitus	7e-06	4.81e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—INS—type 2 diabetes mellitus	6.98e-06	4.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CALM1—type 2 diabetes mellitus	6.94e-06	4.76e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOE—type 2 diabetes mellitus	6.91e-06	4.75e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	6.91e-06	4.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.87e-06	4.72e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOA1—type 2 diabetes mellitus	6.83e-06	4.69e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	6.76e-06	4.64e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.75e-06	4.64e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.75e-06	4.63e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	6.74e-06	4.63e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	6.56e-06	4.51e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	6.48e-06	4.45e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SRC—type 2 diabetes mellitus	6.47e-06	4.44e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS2—type 2 diabetes mellitus	6.44e-06	4.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.41e-06	4.4e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	6.35e-06	4.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—INS—type 2 diabetes mellitus	6.23e-06	4.28e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	6.22e-06	4.27e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IRS1—type 2 diabetes mellitus	6.17e-06	4.23e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGFR—type 2 diabetes mellitus	6.14e-06	4.22e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.12e-06	4.2e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.12e-06	4.2e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	6.1e-06	4.19e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	5.91e-06	4.06e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—INS—type 2 diabetes mellitus	5.91e-06	4.06e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	5.81e-06	3.99e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AKT1—type 2 diabetes mellitus	5.79e-06	3.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	5.79e-06	3.98e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—type 2 diabetes mellitus	5.78e-06	3.97e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RELA—type 2 diabetes mellitus	5.76e-06	3.96e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	5.72e-06	3.93e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	5.71e-06	3.92e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT2—type 2 diabetes mellitus	5.71e-06	3.92e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGFR—type 2 diabetes mellitus	5.67e-06	3.89e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.46e-06	3.75e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	5.46e-06	3.75e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	5.42e-06	3.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.2e-06	3.57e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	5.18e-06	3.56e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS3—type 2 diabetes mellitus	5.18e-06	3.56e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	5.04e-06	3.46e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	5e-06	3.43e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—INS—type 2 diabetes mellitus	4.95e-06	3.4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.91e-06	3.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.86e-06	3.34e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—type 2 diabetes mellitus	4.72e-06	3.24e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	4.53e-06	3.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SRC—type 2 diabetes mellitus	4.53e-06	3.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.41e-06	3.03e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—type 2 diabetes mellitus	4.36e-06	2.99e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AKT1—type 2 diabetes mellitus	4.35e-06	2.99e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.34e-06	2.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	4.34e-06	2.98e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.05e-06	2.78e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—AKT1—type 2 diabetes mellitus	4.02e-06	2.76e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.97e-06	2.73e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SRC—type 2 diabetes mellitus	3.83e-06	2.63e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	3.42e-06	2.35e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGFR—type 2 diabetes mellitus	3.36e-06	2.31e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—type 2 diabetes mellitus	3.05e-06	2.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.81e-06	1.93e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—type 2 diabetes mellitus	2.58e-06	1.77e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	2.51e-06	1.72e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—AKT1—type 2 diabetes mellitus	2.38e-06	1.63e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	1.99e-06	1.37e-05	CbGpPWpGaD
